Opening book details…
About this Medicine article
Study Design and Rationale for a Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy and Safety of Selumetinib in Combination With Docetaxel as Second-Line Treatment in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer (SELECT-1) by Jänne, Pasi A.; Mann, Helen; Ghiorghiu, Dana is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Jänne, Pasi A.; Mann, Helen; Ghiorghiu, Dana
- Publisher
- CIG Media Group, LP.; Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 1525-7304)
- Published
- 2015
- Language
- EN
- Field
- Medicine (Health Sciences)
More by Jänne, Pasi A.; Mann, Helen; Ghiorghiu, Dana
Browse all works by Jänne, Pasi A.; Mann, Helen; Ghiorghiu, Dana